Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation

被引：0
|
作者：
Fahad Shaikh
Lachlan B. Pasch
Phillip J. Newton
Beata V. Bajorek
Caleb Ferguson
机构：
[1] University of Technology Sydney,Discipline of Pharmacy, Graduate School of Health
[2] Western Sydney Nursing and Midwifery Research Centre,undefined
[3] Western Sydney Local Health District and Western Sydney University,undefined
[4] Blacktown Clinical and Research School,undefined
[5] Blacktown Hospital,undefined
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Atrial fibrillation; Multimorbidity; Polypharmacy; Anticoagulation; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation
    Shaikh, Fahad
    Pasch, Lachlan B.
    Newton, Phillip J.
    Bajorek, Beata V.
    Ferguson, Caleb
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (05)
  • [2] Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
    Martinez-Montesinos, Lorena
    Rivera-Caravaca, Jose Miguel
    Agewall, Stefan
    Soler, Eva
    Lip, Gregory Y. H.
    Marin, Francisco
    Roldan, Vanessa
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 158
  • [3] Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
    Kotalczyk, Agnieszka
    Guo, Yutao
    Wang, Yutang
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [4] Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
    Guo, Xueyuan
    Li, Mengmeng
    Du, Xin
    Jiang, Chenxi
    Li, Songnan
    Tang, Ribo
    Sang, Caihua
    Yu, Ronghui
    Long, Deyong
    Dong, Jianzeng
    Ma, Changsheng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] Atrial Fibrillation and Multimorbidity
    Bernard, Michael L.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (12) : 2381 - 2382
  • [6] Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
    Wang, Juan
    Yang, Yan-min
    Zhu, Jun
    Zhang, Han
    Shao, Xing-hui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] Multimorbidity in patients with atrial fibrillation
    Lobeek, Michelle
    Middeldorp, Melissa E.
    Van Gelder, Isabelle C.
    Rienstra, Michiel
    OPEN HEART, 2024, 11 (01):
  • [8] Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
    Koziel, Monika
    Simovic, Stefan
    Pavlovic, Nikola
    Kocijancic, Aleksandar
    Paparisto, Vilma
    Music, Ljilja
    Trendafilova, Elina
    Dan, Anca Rodica
    Kusljugic, Zumreta
    Dan, Gheorghe-Andrei
    Lip, Gregory Y. H.
    Potpara, Tatjana S.
    ANNALS OF MEDICINE, 2021, 53 (01) : 17 - 25
  • [9] NOACs in Atrial Fibrillation Patients with Polypharmacy
    Corica, Bernadette
    Romiti, Giulio Francesco
    Proietti, Marco
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (02) : 149 - 151
  • [10] Multimorbidity in Older Adults with Atrial Fibrillation
    Chen, Michael A.
    CLINICS IN GERIATRIC MEDICINE, 2016, 32 (02) : 315 - +
12345